Idiopathic pulmonary fibrosis: Multiple causes and multiple mechanisms?

European Respiratory Journal

Volumn 30, Issue 5, 2007, Pages 835-839

  Maher, T M ^a,b   Wells, A U ^b   Laurent, G J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Classification; Diagnosis; Idiopathic pulmonary fibrosis; Nonspecific interstitial pneumonia; Pathogenesis

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ASBESTOSIS; COMPUTER ASSISTED TOMOGRAPHY; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SARCOIDOSIS;

ANIMALS; HUMANS; PROGNOSIS; PULMONARY FIBROSIS;

EID: 38849178850     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00069307     Document Type: Review

References (27)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
2. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis. Am J Respir Crir Care Med 1998; 157: 199-203.
3. Nicholson AG, Wells AU. Nonspecific interstitial pneumonia - nobody said it's perfect. Am J Respir Crit Care Med 2001; 164: 1553-1554.
4. Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522-526.
5. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-537.
6. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143-148.
7. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006; 27: 143-150.
8. Yang IV, Burch LH, Steele MP, et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med 2007; 175: 45-54.
9. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006; 173: 188-198.
10. Gauldie J, Jordana M, Cox G. Cytokines and pulmonary fibrosis. Thorax 1993; 48: 931-935.
11. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-151.
12. Benito M, Diaz-Rubio E. Molecular biology in colorectal cancer. Clin Transl Oncol 2006; 8: 391-398.
13. Colebatch A, Hitchins M, Williams R, Meagher A, Hawkins NJ, Ward RL. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer 2006; 95: 1239-1243.
14. Pao W, Wang TY, Riely GJ, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2005; 2: e17.
15. Lawson WE, Lloyd JE. The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease? Proc Am Thorac Soc 2006; 3: 345-349.
16. Vassilakis DA, Sourvinos G, Spandidos DA, Siafakas NM, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2000; 162: 1115-1119.
17. Mori M, Kida H, Morishita H, et al. Microsatellite instability in transforming growth factor-β1 type II receptor gene in alveolar lining cells of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2001; 24: 398-404.
18. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 2006; 3: 364-372.
19. Doram P, Egan JJ. Herpesviruses: a cofactor in the pathogenesis of idiopathic pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 2005; 289: L709-L710.
20. Chambers RC. Role of coagulation cascade proteases in lung repair and fibrosis. Eur Respir J 2003; 22: Suppl. 44, 33s-35s.
21. Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005; 172: 417-422.
22. Thannical VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006; 3: 357-363.
23. Keane MP, Strieter RM, Belperio JA. Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol 2005; 25: 429-463.
24. Willis BC, du Bois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006; 3: 377-382.
25. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007; 353: 104-108.
26. Raghu G, Brown KK, Bradford WZ, et al. A placebo controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004; 350: 125-133.
27. King TE, Behr J, Brown KK, du Bois RM, Raghu G. Bosentan use in idiopathic pulmonary fibrosis (IPF): results of the placebo controlled BUILD-1 study. Am J Respir Crit Care Med 2006; 3: A524.